Tobacco use and urological cancers: An overlooked priority
More details
Hide details
Harvard Medical School, Boston, United States
Publication date: 2023-10-08
Corresponding author
José Ignacio Nolazco   

Harvard Medical School, Boston, United States
Tob. Prev. Cessation 2023;9(Supplement 2):A121
Tobacco smoking is the leading cause of preventable death worldwide. It causes or exacerbates most of the top ten leading malignancies, including bladder, upper urinary tract, kidney, and prostate cancer. Unfortunately, many patients are unaware of these associations. Furthermore, the critical role of urologists in facilitating tobacco cessation throughout target counseling interventions remains vastly underutilized. This presentation examines the association between tobacco smoking and urological cancers and discusses urologists' role in tobacco cessation efforts.

Material and Methods:
A comprehensive literature review examined the association between smoking and urological cancers and urologists' role in tobacco cessation counseling.

Smoking is associated with aggressive tumors, advanced cancer stage, higher risk of recurrence and progression, surgical complications, worse treatment outcomes, and increased cancer-specific mortality in urological cancers. Furthermore, it is associated with other health problems, such as cardiovascular events, lung disease, impaired immune function, poor wound healing, and diminished quality of life. However, few urologists are engaged in tobacco cessation practice.

Urologists are paramount in addressing tobacco use and providing tobacco cessation support to all patients. Urologists should incorporate screening, patient education, and tobacco cessation counseling into routine practice to reduce the tobacco-related disease burden.

The author has no conflicts of interest to disclose.
Journals System - logo
Scroll to top